Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism - PubMed (original) (raw)
Review
Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism
Ariel Y Deutch et al. Parkinsonism Relat Disord. 2007.
Abstract
Current approaches to Parkinson's Disease (PD) are largely based on our current understanding of the mechanisms that contribute to the death of nigrostriatal dopamine neurons. However, our understanding of the consequences of the loss of dopamine on the striatal target cells of nigrostriatal neurons is much less advanced. In particular, the compensatory changes that occur in striatal medium spiny neurons (MSNs) that have lost their normal dopamine input remains poorly understood. The compensatory changes may have either positive or negative effects. Among the alterations that occur in striatal cells of the dopamine-denervated striatum are dystrophic changes in the dendrites of MSNs, with a loss of dendritic length and dendritic spine number. Dendritic spines are the targets of convergent nigrostriatal dopamine and corticostriatal glutamate axons, and integrate these convergent signals to determine the nature of striatal output. The loss of these spines in the dopamine-denervated state may protect the MSN from overt excitotoxic death, but at the price of compromising MSN function. The loss of dendritic spines is thought be responsible for the gradual decrease in levodopa efficacy in late-stage PD, suggesting that therapeutic interventions need to be developed that target key downstream signaling complexes in medium spiny neurons.
Conflict of interest statement
Conflict of Interest statement
The authors have declared no conflicts of interest for the topics addressed in this manuscript. AYD is a consultant for Eli Lilly and Co on other topics.
Similar articles
- Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.
Garcia BG, Neely MD, Deutch AY. Garcia BG, et al. Cereb Cortex. 2010 Oct;20(10):2423-32. doi: 10.1093/cercor/bhp317. Epub 2010 Jan 29. Cereb Cortex. 2010. PMID: 20118184 Free PMC article. - Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
Wei W, Ding S, Zhou FM. Wei W, et al. J Neurophysiol. 2017 Mar 1;117(3):987-999. doi: 10.1152/jn.00683.2016. Epub 2016 Dec 7. J Neurophysiol. 2017. PMID: 27927785 Free PMC article. - Remodeling of the dendritic structure of the striatal medium spiny neurons accompanies behavioral recovery in a mouse model of Parkinson's disease.
Kim W, Im MJ, Park CH, Lee CJ, Choi S, Yoon BJ. Kim W, et al. Neurosci Lett. 2013 Dec 17;557 Pt B:95-100. doi: 10.1016/j.neulet.2013.10.049. Epub 2013 Oct 28. Neurosci Lett. 2013. PMID: 24176882 - Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson's disease.
Deutch AY. Deutch AY. J Neural Transm Suppl. 2006;(70):67-70. doi: 10.1007/978-3-211-45295-0_12. J Neural Transm Suppl. 2006. PMID: 17017511 Review. - Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine?
Villalba RM, Smith Y. Villalba RM, et al. Neuroscience. 2013 Oct 22;251:2-20. doi: 10.1016/j.neuroscience.2013.07.011. Epub 2013 Jul 16. Neuroscience. 2013. PMID: 23867772 Free PMC article. Review.
Cited by
- Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities.
Picconi B, De Leonibus E, Calabresi P. Picconi B, et al. J Neural Transm (Vienna). 2018 Aug;125(8):1263-1271. doi: 10.1007/s00702-018-1864-6. Epub 2018 Feb 28. J Neural Transm (Vienna). 2018. PMID: 29492662 Review. - Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats.
Korkmaz O, Ay H, Ulupinar E, Tunçel N. Korkmaz O, et al. J Mol Neurosci. 2012 Nov;48(3):565-73. doi: 10.1007/s12031-012-9781-x. Epub 2012 Apr 29. J Mol Neurosci. 2012. PMID: 22544516 - Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease.
Lerner RP, Trejo Martinez Ldel C, Zhu C, Chesselet MF, Hickey MA. Lerner RP, et al. Brain Res Bull. 2012 Apr 10;87(6):571-8. doi: 10.1016/j.brainresbull.2012.01.012. Epub 2012 Feb 4. Brain Res Bull. 2012. PMID: 22326483 Free PMC article. - L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.
Suarez LM, Solis O, Aguado C, Lujan R, Moratalla R. Suarez LM, et al. Cereb Cortex. 2016 Oct 17;26(11):4253-4264. doi: 10.1093/cercor/bhw263. Cereb Cortex. 2016. PMID: 27613437 Free PMC article. - Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.
Garcia BG, Neely MD, Deutch AY. Garcia BG, et al. Cereb Cortex. 2010 Oct;20(10):2423-32. doi: 10.1093/cercor/bhp317. Epub 2010 Jan 29. Cereb Cortex. 2010. PMID: 20118184 Free PMC article.
References
- Wickens JR, Arbuthnott GW. Structural and functional interactions in the striatum at the receptor level. In: Dunnett SB, Bentivoglio M, Bjorklund A, Hokfelt T, editors. Dopamine, vol. 21 of Handbook of Chemical Neuroanatomy. Amsterdam: Elsevier; 2005. pp. 199–236.
- Cepeda C, Hurst RS, Altemus KL, Flores-Hernandez J, Calvert CR, Jokel ES, et al. Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol. 1998;85:659–70. - PubMed
- Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF, et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci. 2006;9:251–9. - PubMed
- Crick F. Do spines twitch? Trends Neurosci. 1984;5:44–6.
- DeFelipe J. Brain plasticity and mental processes: Cajal again. Nat Rev Neurosci. 2006;7:811–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous